Literature DB >> 8342999

Survival with colorectal cancer in ulcerative colitis. A study of 102 cases.

A Sugita1, A J Greenstein, M B Ribeiro, D B Sachar, C Bodian, A K Panday, A Szporn, J Pozner, T Heimann, M Palmer.   

Abstract

OBJECTIVE: This study was undertaken to correlate postoperative survival of patients with ulcerative colitis-associated colorectal cancer with the stage, configuration, size, and mucin content of the tumor. SUMMARY BACKGROUND DATA: The factors influencing prognosis in colorectal cancer in the general population are well accepted, but less is known about their influence in cases of colorectal cancer associated with ulcerative colitis.
METHODS: The authors reviewed the records of 102 patients with ulcerative colitis-associated colorectal cancer admitted to The Mount Sinai Hospital between 1959 and 1988. Tumors were classified on independent pathologic review according to histologic stage, configuration, size, and mucin content. Comparisons among survival curves were tested by the generalized Wilcoxon test. Cox regression models were used to examine the joint effects of selected clinicopathologic features on postoperative survival rates.
RESULTS: Complete follow-up was obtained for 93 patients (92%). Overall 5-year actuarial survival was 52%. When factors were analyzed one at a time, survival was significantly poorer among patients with advanced cancer stage, larger tumor size, infiltrating and ulcerating configuration, and high mucin concentration. On multivariate analysis by the Cox regression model, however, only cancer stage emerged as a factor independently predicting survival.
CONCLUSIONS: For colitis-associated colorectal cancers, as for noncolitic cancers, histologic stage is the most important variable determining postoperative survival. The distribution of stages in our series and the survival rates within each stage did not differ appreciably from the distributions and survival rates reported for noncolitic colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342999      PMCID: PMC1242929          DOI: 10.1097/00000658-199308000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  The prognostic significance of direct extension of carcinoma of the colon and rectum.

Authors:  V B ASTLER; F A COLLER
Journal:  Ann Surg       Date:  1954-06       Impact factor: 12.969

2.  Carcinoma of the colon, rectum, and anal canal in young patients.

Authors:  M Recalde; E D Holyoke; E G Elias
Journal:  Surg Gynecol Obstet       Date:  1974-12

3.  Mucinous carcinoma of the colon and rectum.

Authors:  D A Symonds; A L Vickery
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

4.  Carcinoma of the colon and rectum complicating chronic ulcerative colitis.

Authors:  J A van Heerden; R W Beart
Journal:  Dis Colon Rectum       Date:  1980-04       Impact factor: 4.585

5.  Carcinoma of the large bowel in the first four decades.

Authors:  H C Umpleby; R C Williamson
Journal:  Br J Surg       Date:  1984-04       Impact factor: 6.939

6.  Colorectal carcinoma in patients less than 40 years of age.

Authors:  U Ohman
Journal:  Dis Colon Rectum       Date:  1982-04       Impact factor: 4.585

7.  Prognosis of carcinoma in ulcerative colitis.

Authors:  J K Ritchie; P R Hawley; J E Lennard-Jones
Journal:  Gut       Date:  1981-09       Impact factor: 23.059

8.  Colorectal adenocarcinoma in patients less than 40 years old.

Authors:  W W Walton; P F Hagihara; W O Griffen
Journal:  Dis Colon Rectum       Date:  1976-09       Impact factor: 4.585

9.  Survival of 727 patients with single carcinomas of the large bowel.

Authors:  H C Umpleby; J B Bristol; J B Rainey; R C Williamson
Journal:  Dis Colon Rectum       Date:  1984-12       Impact factor: 4.585

10.  The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases.

Authors:  R C Newland; P H Chapuis; M T Pheils; J G MacPherson
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

View more
  14 in total

Review 1.  Ulcerative colitis-associated colorectal cancer.

Authors:  Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

2.  Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits.

Authors:  Bianca W Chang; Aryavarta M S Kumar; Shlomo A Koyfman; Matthew Kalady; Ian Lavery; May Abdel-Wahab
Journal:  Int J Colorectal Dis       Date:  2015-01-08       Impact factor: 2.571

3.  Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort.

Authors:  Hiroki Matsuoka; Hiroki Ikeuchi; Motoi Uchino; Toshihiro Bando; Yoshio Takesue; Takayuki Nishigami; Naohiro Tomita
Journal:  Int J Colorectal Dis       Date:  2012-10-19       Impact factor: 2.571

4.  Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.

Authors:  Bernhard W Renz; Wolfgang E Thasler; Gerhard Preissler; Tobias Heide; Philippe N Khalil; Michael Mikhailov; Karl-Walter Jauch; Martin E Kreis; Markus Rentsch; Axel Kleespies
Journal:  J Gastrointest Surg       Date:  2013-03-09       Impact factor: 3.452

5.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

6.  Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.

Authors:  Jordan Axelrad; Anuja Kriplani; Umut Ozbek; Noam Harpaz; Jean-Frederic Colombel; Steven Itzkowitz; Randall F Holcombe; Celina Ang
Journal:  Clin Colorectal Cancer       Date:  2016-09-20       Impact factor: 4.481

7.  Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.

Authors:  Scott V Adams; Dennis J Ahnen; John A Baron; Peter T Campbell; Steven Gallinger; William M Grady; Loic LeMarchand; Noralane M Lindor; John D Potter; Polly A Newcomb
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

8.  Proctocolectomy for colon cancer associated with ulcerative colitis a few months after living donor liver transplantation for primary sclerosing cholangitis: report of a case.

Authors:  Takasuke Fukuhara; Akinori Egashira; Masakazu Imamura; Toru Ikegami; Eiji Oki; Yuji Soejima; Noriaki Sadanaga; Akinobu Taketomi; Takashi Yao; Masaru Morita; Yoshihiro Kakeji; Masazumi Tsuneyoshi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2009-01-08       Impact factor: 2.549

9.  Increased susceptibility of chronic ulcerative colitis-induced carcinoma development in DNA repair enzyme Ogg1 deficient mice.

Authors:  Jie Liao; Darren N Seril; Gary G Lu; Meng Zhang; Shinya Toyokuni; Allison L Yang; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2008-08       Impact factor: 4.784

Review 10.  Microscopic features of colorectal neoplasia in inflammatory bowel diseases.

Authors:  Aude Bressenot; Virginie Cahn; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.